These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 23314477)

  • 1. Premenstrual syndrome and self-medication with opioids.
    Qurishi R; Sonneborn C; de Jong-Arts M; de Jong C
    J Addict Med; 2013; 7(1):79-82. PubMed ID: 23314477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical management of premenstrual dysphoric disorder.
    Yonkers KA
    J Gend Specif Med; 1999; 2(3):55-60. PubMed ID: 11252853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Methadone in Induction and/or Exacerbation of Cluster Headache in Patients Treated for Opioid Addiction.
    Diot C; Eiden C; Leglise Y; Donnadieu-Rigole H; Peyrière H
    Therapie; 2015; 70(3):305-7. PubMed ID: 25487851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching from methadone to diamorphine: 2-year results of the german heroin-assisted treatment trial.
    Verthein U; Haasen C; Reimer J
    Subst Use Misuse; 2011; 46(8):980-91. PubMed ID: 21235340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irritability and sociability in women with symptomatic premenstrual change.
    Marean M; Fox EE; Cumming CE; Cumming DC
    Women Health; 1998; 27(3):65-71. PubMed ID: 9698638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of beneficial effects of clonidine in the treatment of premenstrual dysphoric disorder: results of a double-blind, randomized study.
    Bunevicius R; Hinderliter AL; Light KC; Pedersen CA; Girdler SS
    Hum Psychopharmacol; 2005 Jan; 20(1):33-9. PubMed ID: 15536640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heroin maintenance treatment: from idea to research to practice.
    Uchtenhagen AA
    Drug Alcohol Rev; 2011 Mar; 30(2):130-7. PubMed ID: 21375613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. After the randomised injectable opiate treatment trial: post-trial investigation of slow-release oral morphine as an alternative opiate maintenance medication.
    Bond AJ; Reed KD; Beavan P; Strang J
    Drug Alcohol Rev; 2012 Jun; 31(4):492-8. PubMed ID: 21919979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Premenstrual dysphoric disorder: diagnostic and therapeutic approach].
    Guedj F
    Rev Prat; 1997 Nov; 47(17):1907-12. PubMed ID: 9453190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Premenstrual syndrome.
    Dickerson LM; Mazyck PJ; Hunter MH
    Am Fam Physician; 2003 Apr; 67(8):1743-52. PubMed ID: 12725453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Change in quality of life and its predictors in heroin users receiving methadone maintenance treatment in Taiwan: an 18-month follow-up study.
    Wang PW; Wu HC; Yen CN; Yeh YC; Chung KS; Chang HC; Yen CF
    Am J Drug Alcohol Abuse; 2012 May; 38(3):213-9. PubMed ID: 22352836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premenstrual exacerbation of depression: one process or two?
    Yonkers KA; White K
    J Clin Psychiatry; 1992 Aug; 53(8):289-92. PubMed ID: 1500406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premenstrual syndrome and premenstrual dysphoric disorder in adolescents.
    Rapkin AJ; Mikacich JA
    Curr Opin Obstet Gynecol; 2008 Oct; 20(5):455-63. PubMed ID: 18797268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
    Freeman EW
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder.
    Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I
    Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Monitoring and evaluation of the Hungarian methadone maintenance programmes].
    Rácz J; Melles K; Márványkövi F; Vadász V
    Psychiatr Hung; 2010; 25(3):202-20. PubMed ID: 20884995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To what extent do premenstrual and interictal dysphoric disorder overlap? Significance for therapy.
    Blumer D; Herzog AG; Himmelhoch J; Salgueiro CA; Ling FW
    J Affect Disord; 1998 Mar; 48(2-3):215-25. PubMed ID: 9543212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of clinical case management in a methadone maintenance treatment program.
    Plater-Zyberk CJ; Varenbut M; Daiter J; Worster A
    Am J Drug Alcohol Abuse; 2012 Jan; 38(1):70-2. PubMed ID: 21823899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness.
    Rapkin AJ; Winer SA
    Expert Rev Pharmacoecon Outcomes Res; 2009 Apr; 9(2):157-70. PubMed ID: 19402804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.